The worst documented peptide emergencies share one feature: not the molecule, but the room it was given in — no screening, no identified product, no oxygen, no plan. RAADfest, a nursing-board anaphylaxis case, and a CDC clinic outbreak.
The pattern
Read the worst cases in this file back to back and a pattern emerges that no compound page can teach: the molecule varies; the setting is the constant. An unidentified product. An administrator whose license doesn’t cover the room they’re standing in. No screening for contraindications. No emergency equipment, or equipment nobody can use. When something goes wrong — and with injectable drugs, something eventually goes wrong — the difference between a scare and an ICU stay is the room.
RAADfest: the purest form
On July 13, 2025, at RAADfest, a longevity conference in Las Vegas, two women — aged 38 and 51 — received injections at a conference booth. Both developed anaphylaxis-type reactions: swollen tongues, respiratory distress. Both were intubated and spent days in intensive care. Both recovered (reported by ProPublica).
Then the detail that defines the case: investigators could never establish what was injected. The product was gone. The cocktail included at least one peptide FDA had flagged as presenting significant safety risks in compounding. The booth physician was not licensed in Nevada. Nevada’s Board of Pharmacy fines totaled $35,000 (early 2026).
No screening could have caught the reaction, because no one can screen against an unknown substance. No emergency plan built on “we know what we gave her” could work, because nobody did.
The clinic that had one expired auto-injector
A state Board of Nursing disciplinary case (complaint dated March 14, 2025; board findings as summarized from the case documents) describes the same failure in a fixed clinic: a client developed anaphylaxis within about 25 minutes of a BPC-157 administration. The clinic’s emergency readiness consisted of one near-expired epinephrine auto-injector, no oxygen, no staff certified in basic life support — and EMS was not promptly activated. The board’s findings were incompetence, an insufficient emergency action plan, and gross negligence.
BPC-157 did not need to be unusually dangerous for this to become a catastrophe in waiting. Any injectable can trigger anaphylaxis. A room that injects people for money is a room that has accepted the obligation to rescue them.
The clinic channel is not automatically sterile, either
In a CDC health alert (September 2026, as reported), more than 25 people across Texas, Washington, Florida, and New York became ill after glutathione injections at wellness clinics beginning in July 2025; at least three were hospitalized and one was in intensive care with shock and abnormal clotting. Glutathione is not a gray-market research peptide — this was the clinic channel itself, the one marketed as the safe alternative, producing an outbreak.
What a medical setting actually consists of
The lesson of all three cases is a checklist the setting owed its patients before the needle:
- An identified product — a named substance, from a known source, recorded in the chart, so an emergency team knows what it is treating.
- Screening — a history that catches the contraindications (cancer history for GH-axis compounds, blood pressure for melanocortins, diabetes for secretagogues) and a list of everything else the patient takes.
- Emergency capability in the room — in-date epinephrine, oxygen, staff trained and certified to use them, and a rehearsed plan that ends with EMS activated, not debated.
- A licensed administrator, practicing where they are licensed.
- A record — so that if something goes wrong, the event enters the safety data instead of vanishing with the product.
A booth has none of these. A med-spa may have some. The two RAADfest patients survived a room that had effectively zero.
Get medical care now if
- Swelling of the lips or tongue, throat tightness, or trouble breathing after any injection — call emergency services immediately. This is the reaction in both cases above, and minutes are the variable.
- Hives spreading across the body, dizziness, or faintness after an injection — same call.
- If you received an injection somewhere that could not tell you exactly what was in it, write down everything you remember — booth, brand names, vial labels — while you can. In the RAADfest case, that information did not exist when investigators needed it.
If you were harmed, report it to FDA MedWatch — and to the state board that licenses the facility. The RAADfest paper trail exists because regulators, not the market, built it.
The bottom line
This site grades molecules carefully, because molecules matter. But the documented emergencies say the first safety question about any injection is not “is this compound safe?” It is “if this goes wrong in the next twenty minutes, what happens in this room?” If the room has no answer, the compound’s file is irrelevant. See also Injection Infections and Contaminated Products & Forged Lab Reports.
Educational information only — not medical or legal advice. Status as of November 9, 2026. See Our Legal Mandate.